Implications of the 2015 World Health Organization isoniazid preventive therapy recommendations on Tuberculosis prevention efforts in Namibia

Simple item page
dc.contributor.authorOloo, Stella A.
dc.date.accessioned2016-09-01T13:52:08Z
dc.date.available2016-09-01T13:52:08Z
dc.date.issued2016
dc.description.abstractThe World Health Organization recently released guidelines recommending 36-month use of isoniazid preventive therapy in adults and adolescents living with HIV in resource-limited settings. Namibia continues to grapple with one of the highest incidences of tuberculosis (TB) worldwide. Implementation of these guidelines requires considerations of TB epidemiology, health infrastructure, programmatic priorities and patient adherence. This article explores the challenges Namibia currently faces in its fight against TB and the implications of the new guidelines on Namibian TB prevention efforts.en_US
dc.identifier.citationOloo, S.A. (2016). Implications of the 2015 World Health Organization isoniazid preventive therapy recommendations on tuberculosis prevention efforts in Namibia. The South African Medical Journal, 106(8), 775-776.en_US
dc.identifier.urihttp://hdl.handle.net/11070/1839
dc.language.isoenen_US
dc.source.urihttp://www.samj.org.za/index.php/samj/article/view/10787en_US
dc.subjectTuberculosisen_US
dc.subjectPreventionen_US
dc.subjectIPTen_US
dc.subjectIsoniased preventive therapyen_US
dc.titleImplications of the 2015 World Health Organization isoniazid preventive therapy recommendations on Tuberculosis prevention efforts in Namibiaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Oloo_2016.pdf
Size:
74.1 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (DIM)